Gut Liver.
2016 Jan;10(1):10-11. 10.5009/gnl15576.
Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis
- Affiliations
-
- 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. yh.paik@skku.edu
- 2Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
- KMID: 2382338
- DOI: http://doi.org/10.5009/gnl15576
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor beta Secretion
- Clinical Effects of Doxazosin in Essential Hypertension
- Severe carvedilol toxicity without overdose – caution in cirrhosis
- Reversal of liver cirrhosis: current evidence and expectations
- Clinical effects of doxazosin in the treatment of essential hypertension
